相关实验视频

Updated: Jul 1, 2025

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

胚胎线CEBPA突变载体的临床特征和管理

Lili Pan¹, Yining Li², Huiying Gao²

¹Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Department of Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, PR China; Union Clinical Medical Colleges, Fujian Medical University, Fuzhou 350001, PR China.

Leukemia research

|March 5, 2024

概括

生殖系CCAAT/增强酶结合蛋白-α (CEBPA) 突变在家族性急性髓性白血病 (AML) 中很罕见. 这项研究详细介绍了临床特征,发现CEBPA^p30突变增加了AML发病率和较低的发病年龄,但提高了生存率.

科学领域:

血液学血液学血液学
遗传学遗传学是一个
在瘤学瘤学.

背景情况:

家庭急性髓性白血病 (AML) 与生殖系CCAAT/增强酶结合蛋白-α (CEBPA) 突变不经常报告.
对临床特征的有限理解阻碍了对这些罕见的家族性AML病例的诊断和管理.

研究的目的:

描述与生殖线CEBPA突变相关的家族性AML的临床特征.
研究不同CEBPA突变类型对AML发病率,发病率和存活率的影响.
为受影响的家庭和携带者提供遗传咨询和管理策略的见解.

主要方法:

来自两个中国家庭的临床数据的回顾性分析,其中有多个AML病例和生殖系CEBPA突变.
在22个具有生殖系CEBPA突变的家族中,来自57名AML患者的数据的整合.
分析突变类型 (N端CEBP/α与C端CEBP/α) 以及它们与临床结果的相关性.

主要成果:

识别了具有生殖系CEBPA突变的家族AML血统,其中包括一个跨越四代的11例病例.
与CEBPA^p30^其他相比,生殖系CEBPA^p30突变 (N-终端) 与更高的AML发病率 (80.36%与42.86%) 和更早的发病率 (18与38.5年) 相关.
尽管复发率高,但家族性AML病例显示出有利的整体存活率,CEBPA携带者表现出更好的结果 (>25年vs11年).

结论:

生殖系CEBPA突变,特别是CEBPA^p30,在家庭环境中显著影响AML的发展和临床过程.
CEBPA^p30携带者具有显著增加的风险和AML的早期发病,但矛盾的是更好的长期存活率.
这些发现支持改善生殖系CEBPA突变和AML的家庭的遗传咨询和临床管理.

关键词:

在AML,AML就是AML.在CEBPA中,CEBPA是CEBPA的成员.这是家族性AML.

更多相关视频

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

相关概念视频

Mutations

Mutations

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

Pedigree Analysis

Pedigree Analysis

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Probability Laws

Probability Laws